Darou Pakhsh

Darou Pakhsh Holding Company (Persian: شرکت کارخانجات داروپخش‎ lit. drug distribution company) is a major pharmaceutical company in Iran. The company is majority-owned by the Social Security Organization of Iran. The company manufactures, distributes, imports and exports finished products and pharmaceutical raw materials. Darou Pakhsh has an annual turnover of US$400m and claims to have the largest research and development operation of any Iranian drug firm.[2] The company formed a plasmapheresis joint venture with a German medical firm, Biotest AG, in early 2004.[2] Darou Pakhsh is listed on the Tehran Stock Exchange.

Darou Pakhsh Holding Company
Public
Traded asTSE: DARO1
ISIN: IRO1DARO0008
IndustryPharmaceuticals, chemicals
Founded1956 (1956) (as Darou Pakhsh)
1997 (as Darou Pakhsh Holding)
HeadquartersTehran , Iran
Area served
Worldwide
ProductsVeterinary drugs, diagnostic imaging, general and specialty medicines, women's health products, over-the-counter drugs, diabetes care, pesticides, plant biotechnology
OwnerTPICO (74.5%)[1]
Websitewww.dpholding.com

History

Initially, the plant had been designed to produce 20 dosage forms. During over 40 years of activity in pharmaceutical industry, the company has been employing many qualified pharmacists, expert chemists, & skilled technicians. Also, modern machinery installation, equipping the laboratory with new analytical instruments, taking advantage of facilities along with decades of gaining scientific knowledge has brought the company up-to-date in all its sections which conform to the latest standards

See also

References
  1. "Daroupakhsh ( DARO1 ) info". tsetmc.com. Retrieved 2012-05-26.
  2. IRAN: Healthcare and Pharmaceuticals Forecast, Economist Intelligence Unit, August 18, 2008
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.